Sargent Bickham Lagudis’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-350
Closed -$7K 806
2017
Q4
$7K Hold
350
﹤0.01% 657
2017
Q3
$6K Hold
350
﹤0.01% 683
2017
Q2
$12K Hold
350
﹤0.01% 552
2017
Q1
$11K Hold
350
﹤0.01% 581
2016
Q4
$13K Sell
350
-202
-37% -$7.5K ﹤0.01% 529
2016
Q3
$25 Sell
552
-448
-45% -$20 ﹤0.01% 451
2016
Q2
$40K Hold
1,000
0.01% 371
2016
Q1
$40K Buy
+1,000
New +$40K 0.01% 397